Bristol-Myers Squibb Company (BMY) vs Merck & Co., Inc. (MRK)
BMY leads on 10 of 17 compared metrics.
A side-by-side comparison of Bristol-Myers Squibb Company and Merck & Co., Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
BMY
Bristol-Myers Squibb Company
$57.13Healthcare
MRK
Merck & Co., Inc.
$119.05Healthcare
Total return — BMY vs MRK
growth of $100 · last 30yBMY +171.1%MRK +287.9%MRK compounded faster
BMY MRK
BMY vs MRK: by the numbers
- •MRK is the larger company ($294.03B vs $116.66B market cap).
- •BMY trades at the lower earnings multiple (16.05 vs 33.54 P/E).
- •BMY converts more revenue to profit (15.01% vs 13.62% net margin).
- •MRK grew revenue faster over the past five years (8.60% vs 2.52% CAGR).
- •BMY pays the higher dividend yield (4.38% vs 2.79%).
Which is better, BMY or MRK?
Metric tally: BMY 10 · MRK 7It depends on what you're optimizing for:
ValueBMY(lower P/E)
GrowthMRK(faster 5Y revenue CAGR)
IncomeBMY(higher dividend yield)
QualityMRK(higher ROIC)
Valuation
| Metric | BMY | MRK |
|---|---|---|
| P/E ratio | 16.05● | 33.54 |
| Forward P/E | 9.31● | 12.35 |
| P/S ratio | 2.41● | 4.49 |
| P/B ratio | 5.82● | 6.41 |
| PEG ratio | 1.71● | 1.81 |
| EV / EBITDA | 11.03● | 19.58 |
| FCF yield | 10.20%● | 4.80% |
Profitability
| Metric | BMY | MRK |
|---|---|---|
| Gross margin | 68.75% | 75.91%● |
| Operating margin | 25.67% | 27.59%● |
| Net margin | 15.01%● | 13.62% |
| ROE | 36.25%● | 19.48% |
| ROIC | 13.90% | 18.27%● |
Dividends
| Metric | BMY | MRK |
|---|---|---|
| Dividend yield | 4.38%● | 2.79% |
| Payout ratio | 72.25% | 45.48% |
Growth (annualized)
| Metric | BMY | MRK |
|---|---|---|
| Revenue CAGR (5Y) | 2.52% | 8.60%● |
| EPS CAGR (5Y) | 9.38% | 21.21%● |
| FCF CAGR (5Y) | -2.50% | 15.69%● |
| Total return CAGR (5Y) | 0.74% | 12.79%● |
Frequently asked
- Which is better, BMY or MRK?
- It depends on your goal. value: BMY (lower P/E); growth: MRK (faster 5Y revenue CAGR); income: BMY (higher dividend yield); quality: MRK (higher ROIC). Across all compared metrics, BMY leads 10 to 7.
- Is BMY or MRK cheaper?
- On trailing earnings, BMY is cheaper: BMY trades at a 16.05 P/E and MRK at 33.54.
- Which has grown faster, BMY or MRK?
- Over the past five years, MRK grew revenue faster — BMY at a 2.52% CAGR versus MRK at 8.60%.
- Does BMY or MRK pay a bigger dividend?
- BMY yields 4.38% and MRK yields 2.79% based on trailing dividends and the latest price.
- Is BMY or MRK more profitable?
- BMY runs the higher net margin — BMY at 15.01% versus MRK at 13.62%.
- Which has been the better investment, BMY or MRK?
- Over the past 10-year, MRK delivered the higher annualized total return — BMY at 1.08% versus MRK at 11.57%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bristol-Myers Squibb P/E ratioMerck & P/E ratioBristol-Myers Squibb dividend yieldMerck & dividend yieldBristol-Myers Squibb ROEMerck & ROEBristol-Myers Squibb operating marginMerck & operating marginBristol-Myers Squibb revenue growthMerck & revenue growthBristol-Myers Squibb free cash flowMerck & free cash flow
Bristol-Myers Squibb & Merck & appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.